ฟลูอ็อกเซทีน
เชิงอรรถและอ้างอิง

1 2 3 4 5 6  "Fluoxetine Hydrochloride". The American Society of Health-System Pharmacists. สืบค้นเมื่อ 2 December 2015.
1 2 3 4 5  "Prozac Label" (PDF). FDA. 2014. สืบค้นเมื่อ 5 April 2016.
1 2 3 4 5 6 7 8 9 10  "PROZAC® Fluoxetine Hydrochloride" (PDF). TGA eBusiness Services. Eli Lilly Australia Pty. Limited. 9 October 2013. สืบค้นเมื่อ 23 November 2013.
1 2  Altamura, AC; Moro, AR; Percudani, M (March 1994). "Clinical Pharmacokinetics of Fluoxetine" (PDF). Clinical Pharmacokinetics. 26 (3): 201–214. doi:10.2165/00003088-199426030-00004. PMID 8194283.
↑  "Fluoxetine Pregnancy and Breastfeeding Warnings". สืบค้นเมื่อ 2 December 2015.
↑  Myers, Richard L. (2007). The 100 most important chemical compounds : a reference guide (1. publ. ed.). Westport, Conn.: Greenwood Press. p. 128. ISBN 9780313337581.
↑  "WHO Model List of Essential Medicines" (PDF). World Health Organization. October 2013. สืบค้นเมื่อ 22 April 2014.
↑  Hagerman, Randi Jenssen (16 September 1999). Neurodevelopmental Disorders: Diagnosis and Treatment. Oxford University Press. ISBN 019512314X. Dech and Budow (1991) were among the first to report the anecdotal use of fluoxetine in a case of PWS to control behavior problems, appetite, and trichotillomania.
↑  Truven Health Analytics, Inc. DrugPoint® System (Internet) [cited 2013 Oct 4]. Greenwood Village, CO: Thomsen Healthcare; 2013.
↑  Australian Medicines Handbook 2013. The Australian Medicines Handbook Unit Trust; 2013.
↑  British National Formulary (BNF) 65. Pharmaceutical Pr; 2013.
↑  "Fluoxetine Hydrochloride". The American Society of Health-System Pharmacists. สืบค้นเมื่อ 3 April 2011.
↑  "NIMH•Eating Disorders". The National Institute of Mental Health. National Institute of Health. 2011. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 19 August 2011. สืบค้นเมื่อ 25 November 2013.
↑  
Williams, K. (August 2010). "Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)". Cochrane Database of Systematic Reviews. 8: CD004677. doi:10.1002/14651858.CD004677.pub3. PMID 23959778.
↑  
Myers, SM (August 2007). "The status of pharmacotherapy for autism spectrum disorders". Expert Opinion on Pharmacotherapy. 8 (11): 1579–1603. doi:10.1517/14656566.8.11.1579. PMID 17685878.
↑  
Doyle, CA; McDougle, CJ (August 2012). "Pharmacotherapy to control behavioral symptoms in children with autism". Expert Opinion on Pharmacotherapy. 13 (11): 1615–1629. doi:10.1517/14656566.2012.674110. PMID 22550944.
↑  
Benvenuto, A; Battan, B; Porfirio, MC; Curatolo, P (February 2013). "Pharmacotherapy of autism spectrum disorders". Brain and Development. 35 (2): 119–127. doi:10.1016/j.braindev.2012.03.015. PMID 22541665.
↑  Kirsch, Irving; Deacon, BJ; Huedo-Medina, TB; Scoboria, A; Moore, TJ; Johnson, BT (2008). "Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration". PLoS Medicine. PLoS Med. 5 (2): e45. doi:10.1371/journal.pmed.0050045. PMC 2253608. PMID 18303940.
↑  Fournier, Jay C; DeRubeis, Robert J; Hollon, Steven D; Dimidjian, Sona; Amsterdam, Jay D; Shelton, Richard C; Fawcett, Jan (2010). "Antidepressant Drug Effects and Depression Severity". The Journal of the American Medical Association. 303 (1): 47–53. doi:10.1001/jama.2009.1943. PMC 3712503. PMID 20051569. สืบค้นเมื่อ 24 March 2013.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Gibbons, RD; Hur, K; Brown, CH; Davis, JM; Mann, JJ (June 2012). "Benefits from antidepressants: synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine". Arch. Gen. Psychiatry. 69 (6): 572–9. doi:10.1001/archgenpsychiatry.2011.2044. PMC 3371295. PMID 22393205.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  "CG90 Depression in adults: full guidance". National Institute for Health and Care Excellence. คลังข้อมูลเก่าเก็บจากแหล่งเดิม (PDF)เมื่อ 2014-01-09. สืบค้นเมื่อ 1 September 2016.
↑  "PsychiatryOnline | APA Practice Guidelines | Practice Guideline for the Treatment of Patients With Major Depressive Disorder, Third Edition". คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 19 February 2014. สืบค้นเมื่อ 1 September 2016.
1 2  แนวทางการจัดการโรคซึมเศร้าสำหรับแพทย์เวชปฏิบัติทั่วไป, "Summary of Recommendations", หน้า 13-14
↑  "Practice parameter for the assessment and treatment of children and adolescents with obsessive-compulsive disorder". J Am Acad Child Adolesc Psychiatry. 51 (1): 98–113. January 2012. doi:10.1016/j.jaac.2011.09.019. PMID 22176943.
↑  Aigner, Martin; Treasure, Janet; Kaye, Walter; Kasper, Siegfried (December 2011). "World Federation of Societies of Biological Psychiatry (WFSBP) - Guidelines for the Pharmacological Treatment of Eating Disorders" (PDF). The World Journal of Biological Psychiatry. World Federation of Societies of Biological Psychiatry. 12: 400–443. doi:10.3109/15622975.2011.602720. ISSN 1814-1412. PMID 21961502. คลังข้อมูลเก่าเก็บจากแหล่งเดิม (PDF)เมื่อ 1 August 2014. สืบค้นเมื่อ 1 September 2016.
↑  
"Sarafem label" (PDF). FDA. สืบค้นเมื่อ 31 October 2014.
↑  
Rapkin, AJ; Lewis, EI (November 2013). "Treatment of premenstrual dysphoric disorder". Womens Health (Lond Engl). 9 (6): 537–56. doi:10.2217/whe.13.62. PMID 24161307.
↑  
Taurines, R; Gerlach, M; Warnke, A; Thome, J; Wewetzer, C (September 2011). "Pharmacotherapy in depressed children and adolescents". The World Journal of Biological Psychiatry. 12 (Suppl 1): 11–15. doi:10.3109/15622975.2011.600295. PMID 21905988.
↑  
Cohen, D (2007). "Should the use of selective serotonin reuptake inhibitors in child and adolescent depression be banned?". Psychotherapy and psychosomatics. 76 (1): 5–14. doi:10.1159/000096360. PMID 17170559.
↑  
Morrison, JL; Riggs, KW; Rurak, DW (March 2005). "Fluoxetine during pregnancy: impact on fetal development". Reproduction, Fertility and Development. 17 (6): 641–650. doi:10.1071/RD05030. PMID 16263070.
1 2 3  
Brayfield, A, บ.ก. (13 August 2013). Fluoxetine Hydrochloride. Martindale: The Complete Drug Reference. London, UK: Pharmaceutical Press. สืบค้นเมื่อ 24 November 2013.(ต้องรับบริการ)
↑  "Fluoxetine in pregnancy: slight risk of heart defects in unborn child" (PDF). MHRA. Medicines and Healthcare Products Regulatory Agency. 10 September 2011. คลังข้อมูลเก่าเก็บจากแหล่งเดิม (PDF)เมื่อ 2 December 2013. สืบค้นเมื่อ 23 November 2013.
↑  PMID 23660045 (PMID 23660045)
Citation will be completed automatically in a few minutes. 
Jump the queue  or expand by hand (15) 30965-8/pdf Full ArticlePDF
↑  doi:10.1177/0890334409342071
This citation will be automatically completed in the next few minutes. You can jump the queue or  Full Article PDF (211 KB) Archive 2016-08-29 PDF (211 KB)
↑  Taylor, D; Paton, C; Shitij, K (2012). The Maudsley prescribing guidelines in psychiatry. West Sussex: Wiley-Blackwell. ISBN 978-0-470-97948-8.{{cite book}}:  CS1 maint: multiple names: authors list (ลิงก์)
↑  Bland, RD; Clarke, TL; Harden, LB และคณะ (February 1976). "Rapid infusion of sodium bicarbonate and albumin into high-risk premature infants soon after birth: a controlled, prospective trial". Am. J. Obstet. Gynecol. 124 (3): 263–7. PMID 2013.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Koda-Kimble, MA; Alldredge, BK (2012). Applied therapeutics: the clinical use of drugs (10th ed.). Baltimore: Wolters Kluwer Health/Lippincott Williams & Wilkins. ISBN 978-1609137137.
↑  Clark, MS; Jansen, K; Bresnahan, M (November 2013). "Clinical inquiry: How do antidepressants affect sexual function?". J Fam Pract. 62 (11): 660–1. PMID 24288712.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  
Csoka, AB; Csoka, A; Bahrick, A; Mehtonen, OP (2008). "Persistent sexual dysfunction after discontinuation of selective serotonin reuptake inhibitors". The Journal of Sexual Medicine. 5 (1): 227–33. doi:10.1111/j.1743-6109.2007.00630.x. PMID 18173768.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  
Csoka, AB; Shipko, S (2006). "Persistent sexual side effects after SSRI discontinuation" (PDF). Psychotherapy and Psychosomatics. 75 (3): 187–8. doi:10.1159/000091777. PMID 16636635. สืบค้นเมื่อ 2014-01-30.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Calil, HM (2001). "Fluoxetine: a suitable long-term treatment". J Clin Psychiatry. 62 Suppl 22: 24–9. PMID 11599644.
↑  
Rosenbaum, JF; Zajecka, J (1997). "Clinical management of antidepressant discontinuation". The Journal of Clinical Psychiatry. 58 Suppl 7: 37–40. PMID 9219493.
↑  
Schatzberg, AF; Blier, P; Delgado, PL; Fava, M; Haddad, PM; Shelton, RC (2006). "Antidepressant discontinuation syndrome: Consensus panel recommendations for clinical management and additional research". The Journal of Clinical Psychiatry. 67 Suppl 4: 27–30. PMID 16683860.
↑  Fava, M (2006). "Prospective studies of adverse events related to antidepressant discontinuation". The Journal of Clinical Psychiatry. 67 Suppl 4: 14–21. PMID 16683858.
↑  Gartlehner, G; Hansen, RA; Thieda, P; Deveaugh-Geiss, AM; Gaynes, BN; Krebs, EE; Lux, LJ; Morgan, LC; Shumate, JA (January 2007). Comparative Effectiveness of Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression (PDF). Comparative Effectiveness Reviews. Rockville, MD: Agency for Healthcare Research and Quality (US). PMID 20704050.
↑  "Antidepressant Use in Children, Adolescents, and Adults". FDA. 2 May 2007.
↑  
Levenson, M; Holland, C. "Antidepressants and Suicidality in Adults: Statistical Evaluation. (Presentation at Psychopharmacologic Drugs Advisory Committee; December 13, 2006)". สืบค้นเมื่อ 13 May 2007.{{cite web}}:  CS1 maint: uses authors parameter (ลิงก์)
1 2  
Stone, MB; Jones, ML (17 November 2006). "Clinical Review: Relationship Between Antidepressant Drugs and Suicidality in Adults" (PDF). Overview for December 13 Meeting of Psychopharmacologic Drugs Advisory Committee (PDAC). FDA. pp. 11–74. สืบค้นเมื่อ 22 September 2007.{{cite web}}:  CS1 maint: uses authors parameter (ลิงก์)
1 2  
Levenson, M; Holland, C (17 November 2006). "Statistical Evaluation of Suicidality in Adults Treated with Antidepressants" (PDF). Overview for December 13 Meeting of Psychopharmacologic Drugs Advisory Committee (PDAC). FDA. pp. 75–140. สืบค้นเมื่อ 22 September 2007.{{cite web}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Klein, Donald F (2005). "The Flawed Basis for FDA Post-Marketing Safety Decisions: The Example of Anti-Depressants and Children". Neuropsychopharmacology. 31 (4): 689–99. doi:10.1038/sj.npp.1300996. PMID 16395296.
↑  Hammad, Tarek A (13 September 2004). "Results of the Analysis of Suicidality in Pediatric Trials of Newer Antidepressants" (PDF). Presentation at the Meeting of Psychopharmacologic Drugs Advisory Committee and the Pediatric Advisory Committee on September 13, 2004. FDA. pp. 25, 28. สืบค้นเมื่อ 2008-01-06.
↑  
Committee on Safety of Medicines Expert Working Group (December 2004). "Report on The Safety of Selective Serotonin Reuptake Inhibitor Antidepressants" (PDF). Medicines and Healthcare products Regulatory Agency. เก็บ (PDF)จากแหล่งเดิมเมื่อ 1 August 2013. สืบค้นเมื่อ 26 August 2016.
↑  
Gunnell, D.; Saperia, J; Ashby, D (2005). "Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: Meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review". BMJ. 330 (7488): 385. doi:10.1136/bmj.330.7488.385. PMC 549105. PMID 15718537.
↑  "Toxicity". Fluoxetine. PubChem. NCBI. สืบค้นเมื่อ 13 March 2015.
1 2  
Sager, JE; Lutz, JD; Foti, RS; Davis, C; Kunze, KL; Isoherranen, N (June 2014). "Fluoxetine- and Norfluoxetine-Mediated Complex Drug-Drug Interactions: In Vitro to In Vivo Correlation of Effects on CYP2D6, CYP2C19, and CYP3A4". Clinical Pharmacology & Therapeutics. 95 (6): 653–62. doi:10.1038/clpt.2014.50. PMC 4029899. PMID 24569517.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  
Ciraulo, DA; Shader, RI, บ.ก. (2011). Pharmacotherapy of Depression. SpringerLink (2nd ed.). New York, NY: Humana Press. doi:10.1007/978-1-60327-435-7. ISBN 978-1-60327-434-0.
1 2  Sandson, Neil B.; Armstrong, Scott C.; Cozza, Kelly L. (2005). "An Overview of Psychotropic Drug-Drug Interactions". Psychosomatics. 46 (5): 464–94. doi:10.1176/appi.psy.46.5.464. PMID 16145193.
↑  An extensive list of possible interactions is available in Lexi-Comp (September 2008). "Fluoxetine". Merck Manual of Diagnosis and Therapy. สืบค้นเมื่อ 28 December 2008.
↑  Roth, BL; Driscol, J (2011-01-12). "PDSP Ki Database". Psychoactive Drug Screening Program (PDSP). University of North Carolina at Chapel Hill and the United States National Institute of Mental Health. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 8 November 2013. สืบค้นเมื่อ 24 June 2013.
↑  Owens, MJ; Knight, DL; Nemeroff, CB (1 September 2001). "Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine". Biological Psychiatry. 50 (5): 345–50. doi:10.1016/s0006-3223(01)01145-3. PMID 11543737.
↑  
Perry, K. W.; Fuller, R. W. (1997). "Fluoxetine increases norepinephrine release in rat hypothalamus as measured by tissue levels of MHPG-SO4 and microdialysis in conscious rats". Journal of Neural Transmission. 104 (8–9): 953–66. doi:10.1007/BF01285563. PMID 9451727.
↑  
Bymaster, Frank; Zhang, Wei; Carter, Petra; Shaw, Janice; Chernet, Eyassu; Phebus, Lee; Wong, David; Perry, Kenneth (2002). "Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex via serotonin type 2C antagonism". Psychopharmacology. 160 (4): 353–61. doi:10.1007/s00213-001-0986-x. PMID 11919662.
1 2  
Koch, S; Perry, KW; Nelson, DL; Conway, RG; Threlkeld, PG; Bymaster, FP (2002). "R-fluoxetine Increases Extracellular DA, NE, As Well As 5-HT in Rat Prefrontal Cortex and Hypothalamus an in vivo Microdialysis and Receptor Binding Study". Neuropsychopharmacology. 27 (6): 949–59. doi:10.1016/S0893-133X(02)00377-9. PMID 12464452.
1 2 3  
Pinna, G; Costa, E; Guidotti, A (February 2009). "SSRIs act as selective brain steroidogenic stimulants (SBSSs) at low doses that are inactive on 5-HT reuptake". Curr Opin Pharmacol. 9 (1): 24–30. doi:10.1016/j.coph.2008.12.006. PMC 2670606. PMID 19157982.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  
Miguelez, C.; Fernandez-Aedo, I.; Torrecilla, M.; Grandoso, L.; Ugedo, L. (2009). "Α2-Adrenoceptors mediate the acute inhibitory effect of fluoxetine on locus coeruleus noradrenergic neurons". Neuropharmacology. 56 (6–7): 1068–73. doi:10.1016/j.neuropharm.2009.03.004. PMID 19298831.
↑  Pälvimäki, EP; Roth, BL; Majasuo, H และคณะ (August 1996). "Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor". Psychopharmacology. 126 (3): 234–40. doi:10.1007/BF02246453. PMID 8876023.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  
Brunton, PJ (2015). "Neuroactive steroids and stress axis regulation: Pregnancy and beyond". The Journal of Steroid Biochemistry and Molecular Biology. 160: 160–168. doi:10.1016/j.jsbmb.2015.08.003. PMID 26259885.
↑  doi:10.1073/pnas.95.6.3239
This citation will be automatically completed in the next few minutes. You can jump the queue or
↑  doi:10.1038/nrd3502
This citation will be automatically completed in the next few minutes. You can jump the queue or
↑  
Gulbins, Erich; Palmada, Monica; Reichel, Martin; Lüth, Anja; Böhmer, Christoph; Amato, Davide; Müller, Christian P; Tischbirek, Carsten H; Groemer, Teja W; Tabatabai, Ghazaleh; Becker, Katrin A; Tripal, Philipp; Staedtler, Sven; Ackermann, Teresa F; van Brederode, Johannes; Alzheimer, Christian; Weller, Michael; Lang, Undine E; Kleuser, Burkhard; Grassmé, Heike; Kornhuber, Johannes (June 2013). "Acid sphingomyelinase-ceramide system mediates effects of antidepressant drugs". Nature Medicine. 19: 934–938. doi:10.1038/nm.3214.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  
Brunkhorst, R; Friedlaender, F; Ferreirós, N; Schwalm, S; Koch, A; Grammatikos, G; Toennes, S; Foerch, C; Pfeilschifter, J; Pfeilschifter, W (October 2015). "Alterations of the Ceramide Metabolism in the Peri-Infarct Cortex Are Independent of the Sphingomyelinase Pathway and Not Influenced by the Acid Sphingomyelinase Inhibitor Fluoxetine". Neural Plasticity. 2015: 1–10. doi:10.1155/2015/503079. PMC 4641186. PMID 26605090.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  
Narita, N; Hashimoto, K; Tomitaka, S; Minabe, Y (June 1996). "Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain". European Journal of Pharmacology. 307 (1): 117–9. doi:10.1016/0014-2999(96)00254-3. PMID 8831113.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Hashimoto, K (September 2009). "Sigma-1 receptors and selective serotonin reuptake inhibitors: clinical implications of their relationship". Central Nervous System Agents in Medicinal Chemistry. 9 (3): 197–204. doi:10.2174/1871524910909030197. PMID 20021354. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 25 May 2013. สืบค้นเมื่อ 19 August 2021.
↑  
"Fluoxetine". IUPHAR Guide to Pharmacology. IUPHAR. สืบค้นเมื่อ 10 November 2014.
↑  
"Calcium activated chloride channel". IUPHAR Guide to Pharmacology. IUPHAR. สืบค้นเมื่อ 10 November 2014.
1 2  Robinson, RT; Drafts, BC; Fisher, JL (2003). "Fluoxetine increases GABA (A) receptor activity through a novel modulatory site". J. Pharmacol. Exp. Ther. 304 (3): 978–84. doi:10.1124/jpet.102.044834. PMID 12604672.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
1 2  "Prozac Pharmacology, Pharmacokinetics,Studies, Metabolism". RxList.com. 2007. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 10 April 2007. สืบค้นเมื่อ 14 April 2007.
↑  Mandrioli, R.; Forti, G. C.; Raggi, M. A. (2006). "Fluoxetine Metabolism and Pharmacological Interactions: The Role of Cytochrome P450". Current Drug Metabolism. 7 (2): 127–33. doi:10.2174/138920006775541561. PMID 16472103.
↑  Hiemke, Christoph; Härtter, Sebastian (2000). "Pharmacokinetics of selective serotonin reuptake inhibitors". Pharmacology & Therapeutics. 85: 11–28. doi:10.1016/S0163-7258(99)00048-0.
1 2  
Burke, William J.; Hendricks, Shelton E.; McArthur-Miller, Delores; Jacques, Daniel; Bessette, Diane; McKillup, Tracy; Stull, Todd; Wilson, James (2000). "Weekly Dosing of Fluoxetine for the Continuation Phase of Treatment of Major Depression: Results of a Placebo-Controlled, Randomized Clinical Trial". Journal of Clinical Psychopharmacology. 20 (4): 423–7. doi:10.1097/00004714-200008000-00006. PMID 10917403.
↑  "Drug Treatments in Psychiatry: Antidepressants". Newcastle University School of Neurology, Neurobiology and Psychiatry. 2005. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 17 April 2007. สืบค้นเมื่อ 14 April 2007.
1 2  
Pérez, Victor; Puiigdemont, Dolors; Gilaberte, Inmaculada; Alvarez, Enric; Artigas, Francesc; Grup de Recerca en Trastorns Afectius (2001). "Augmentation of Fluoxetine's Antidepressant Action by Pindolol: Analysis of Clinical, Pharmacokinetic, and Methodologic Factors". Journal of Clinical Psychopharmacology. 21 (1): 36–45. doi:10.1097/00004714-200102000-00008. PMID 11199945.
↑  
Brunswick, David J.; Amsterdam, Jay D.; Fawcett, Jan; Quitkin, Frederic M.; Reimherr, Frederick W.; Rosenbaum, Jerrold F.; Beasley Jr, Charles M. (2002). "Fluoxetine and norfluoxetine plasma concentrations during relapse-prevention treatment". Journal of Affective Disorders. 68 (2–3): 243–9. doi:10.1016/S0165-0327(00)00333-5. PMID 12063152.
1 2  Henry, Michael E; Schmidt, Mark E; Hennen, John; Villafuerte, Rosemond A; Butman, Michelle L; Tran, Pierre; Kerner, Lynn T; Cohen, Bruce; Renshaw, Perry F (2005). "A Comparison of Brain and Serum Pharmacokinetics of R-Fluoxetine and Racemic Fluoxetine: A 19-F MRS Study". Neuropsychopharmacology. 30 (8): 1576–83. doi:10.1038/sj.npp.1300749. PMID 15886723.
↑  
Lemberger, L; Bergstrom, RF; Wolen, RL; Farid, NA; Enas, GG; Aronoff, GR (1985). "Fluoxetine: Clinical pharmacology and physiologic disposition". The Journal of Clinical Psychiatry. 46 (3 Pt 2): 14–9. PMID 3871765.
↑  
Pato, MT; Murphy, DL; Devane, CL (1991). "Sustained plasma concentrations of fluoxetine and/or norfluoxetine four and eight weeks after fluoxetine discontinuation". Journal of Clinical Psychopharmacology. 11 (3): 224–5. doi:10.1097/00004714-199106000-00024. PMID 1741813.
↑  
Baselt, R (2008). Disposition of Toxic Drugs and Chemicals in Man (8th ed.). Foster City, CA: Biomedical Publications.{{cite book}}:  CS1 maint: uses authors parameter (ลิงก์)
1 2  Verispan. "Top 200 Generic Drugs by Units in 2010" (PDF). Drug Topics.
↑  Macnair, Patrisha (September 2012). "BBC - Health: Prozac". BBC. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 11 December 2012. In 2011 over 43 million prescriptions for antidepressants were handed out in the UK and about 14 per cent (or nearly 6 million prescriptions) of these were for a drug called fluoxetine, better known as Prozac.
1 2  Wong, David T.; Bymaster, Frank P.; Engleman, Eric A. (1995). "Prozac (fluoxetine, lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: Twenty years since its first publication". Life Sciences. 57 (5): 411–41. doi:10.1016/0024-3205(95)00209-O. PMID 7623609.
1 2  Wong, David T.; Horng, Jong S.; Bymaster, Frank P.; Hauser, Kenneth L.; Molloy, Bryan B. (1974). "A selective inhibitor of serotonin uptake: Lilly 110140, 3- (p-Trifluoromethylphenoxy) -n-methyl-3-phenylpropylamine". Life Sciences. 15 (3): 471–9. doi:10.1016/0024-3205(74)90345-2. PMID 4549929.
1 2  Breggin, Peter R.; Ginger Ross Breggin (1995). Talking Back to Prozac. Macmillan Publishers. pp. 1-2. ISBN 978-0-312-95606-6.
↑  Swiatek, Jeff (2 August 2001). "Prozac's profitable run coming to an end for Lilly". The Indianapolis Star. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 18 August 2007. สืบค้นเมื่อ 1 September 2016.
↑  "Electronic Orange Book". Food and Drug Administration. April 2007. สืบค้นเมื่อ 24 May 2007.
↑  "Lilly Goes Off Prozac The drugmaker bounced back from the loss of its blockbuster, but the recovery had costs". Fortune Magazine. 28 June 2004. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 26 April 2016. สืบค้นเมื่อ 1 September 2016.
1 2  Class, Selena (2 December 2002). "Pharma Overview". สืบค้นเมื่อ 15 June 2009.
↑  
"Lilly menstrual drug OK'd". CNN. 6 July 2000.
↑  
Mechatie, Elizabeth (1 December 1999). "FDA Panel Agrees Fluoxetine Effective For PMDD". International Medical News Group.
↑  "A Biotech Phoenix Could Be Rising". Forbes. 25 September 2002.
↑  "Drug Maker Is Set to Ship Generic Prozac". New York Times. 2 August 2001.
↑  "Patent Expiration Dates for Common Brand-Name Drugs". สืบค้นเมื่อ 20 July 2007.
1 2 3  "Sarafem Nation". Village Voice. 5 December 2000. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2018-06-17. สืบค้นเมื่อ 2016-09-01.
↑  
"Galen to Pay $295 Million For U.S. Rights to Lilly Drug". Wall Street Journal. 9 December 2002.
↑  
"Galen takes Lilly's reinvented Prozac". Telegraph. 10 December 2002.
↑  "New Medicines Seldom Contain Anything New, Study Finds". New York Times. 29 May 2002.
↑  "Renamed Prozac Fuels Women's Health Debate". Washington Post. 29 April 2001.
↑  "Press Release - FAA Proposes New Policy on Antidepressants for Pilots". Faa.gov. 2 April 2010. สืบค้นเมื่อ 10 February 2012.
↑  Ravilious, K (16 July 2010). "Prozac Pollution Making Shrimp Reckless". National Geographic. สืบค้นเมื่อ 25 November 2013.
↑  Work Group On Major Depressive Disorder (October 2010). "Practice Guideline for the Treatment of Patients With Major Depressive Disorder" (PDF) (3rd ed.). PsychiatryOnline. สืบค้นเมื่อ 30 August 2016.
↑  "Depression in adults (update) (CG90)". October 2009. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 29 June 2014.
↑  Gartlehner, Gerald; Gaynes, Bradley N; Hansen, Richard A; Thieda, Patricia; DeVeaugh-Geiss, Angela; Krebs, Erin E; Moore, Charity G; Morgan, Laura; Lohr, Kathleen N (18 November 2008). "Comparative Benefits and Harms of Second-Generation Antidepressants: Background Paper for the American College of Physicians". Annals of Internal Medicine. สืบค้นเมื่อ 30 August 2016.{{cite web}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  "Pharmacological treatment of mental disorders in primary health care" (PDF). WHO. 2009. คลังข้อมูลเก่าเก็บจากแหล่งเดิม (PDF)เมื่อ 2013-12-28. สืบค้นเมื่อ 2016-09-01.
↑  
Möller, HJ; Bitter, I; Bobes, J; Fountoulakis, K; Höschl, C; Kasper, S (February 2012). "Position statement of the European Psychiatric Association (EPA) on the value of antidepressants in the treatment of unipolar depression". Eur. Psychiatry. 27 (2): 114–28. doi:10.1016/j.eurpsy.2011.08.002. PMID 22119161.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  "Causation, bias and confounding: a hitchhiker's guide to the epidemiological galaxy". BMJ.
↑  George, DT; Phillips, MJ; Lifshitz, M และคณะ (January 2011). "Fluoxetine treatment of alcoholic perpetrators of domestic violence: a 12-week, double-blind, randomized, placebo-controlled intervention study". J Clin Psychiatry. 72 (1): 60–5. doi:10.4088/JCP.09m05256gry. PMC 3026856. PMID 20673556.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Coccaro, EF; Lee, RJ; Kavoussi, RJ (May 2009). "A double-blind, randomized, placebo-controlled trial of fluoxetine in patients with intermittent explosive disorder". J Clin Psychiatry. 70 (5): 653–62. doi:10.4088/JCP.08m04150. PMID 19389333.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Coccaro, EF; Kavoussi, RJ (December 1997). "Fluoxetine and impulsive aggressive behavior in personality-disordered subjects". Arch. Gen. Psychiatry. 54 (12): 1081–8. doi:10.1001/archpsyc.1997.01830240035005. PMID 9400343.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  
Stark, LJ; Spirito, A; Williams, CA; Guevremont, DC (April 1989). "Common problems and coping strategies. I: Findings with normal adolescents". J Abnorm Child Psychol. 17 (2): 203–12. doi:10.1007/BF00913794. PMID 2745900.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)